atezolizumab,xl092
exelixis,roche
['xl092', 'xl092 ', 'stellar-001', 'solid tumor', 'exelixis', '$exel']
$exel exelixis announces dose-escalation results from the phase 1 stellar-001 trial evaluating xl092 alone and in combination with an immune checkpoint inhibitor in patients with advanced solid tumors at esmo 2022 
This is an automated account sharing new press releases in real time from https://t.co/7iCFuj68H6